178 related articles for article (PubMed ID: 23770382)
21. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
22. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat.
Colak MC; Parlakpinar H; Tasdemir S; Samdanci E; Kose E; Polat A; Sarihan E; Acet A
Hum Exp Toxicol; 2012 Sep; 31(9):945-54. PubMed ID: 22354086
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and cardiotoxicity of doxorubicin and its secondary alcohol metabolite in rats.
Zeng X; Cai H; Yang J; Qiu H; Cheng Y; Liu M
Biomed Pharmacother; 2019 Aug; 116():108964. PubMed ID: 31102935
[TBL] [Abstract][Full Text] [Related]
25. Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin.
Assumpção JU; Campos ML; Ferraz Nogueira Filho MA; Pestana KC; Baldan HM; Formariz Pilon TP; de Oliveira AG; Peccinini RG
J Pharm Sci; 2013 Jan; 102(1):289-96. PubMed ID: 23150468
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
28. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
29. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats.
Xu M; Sheng L; Zhu X; Zeng S; Chi D; Zhang GJ
Tumori; 2010; 96(3):460-4. PubMed ID: 20845809
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Lu Y; Pan J; Zhu X; Zhang S; Liu C; Sun J; Li Y; Chen S; Huang J; Cao C; Wang Y; Li Y; Liu T
BMC Pharmacol Toxicol; 2021 Sep; 22(1):48. PubMed ID: 34488896
[TBL] [Abstract][Full Text] [Related]
32. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
33. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.
Elberry AA; Abdel-Naim AB; Abdel-Sattar EA; Nagy AA; Mosli HA; Mohamadin AM; Ashour OM
Food Chem Toxicol; 2010 May; 48(5):1178-84. PubMed ID: 20146931
[TBL] [Abstract][Full Text] [Related]
34. The Effects of Mangiferin (Mangifera indica L) in Doxorubicin-induced Cardiotoxicity in Rats.
Arozal W; Suyatna FD; Juniantito V; Rosdiana DS; Amurugam S; Aulia R; Monayo ER; Siswandi R
Drug Res (Stuttg); 2015 Nov; 65(11):574-80. PubMed ID: 25426848
[TBL] [Abstract][Full Text] [Related]
35. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
36. Fucoidan from Fucus vesiculosus attenuates doxorubicin-induced acute cardiotoxicity by regulating JAK2/STAT3-mediated apoptosis and autophagy.
Zhang J; Sun Z; Lin N; Lu W; Huang X; Weng J; Sun S; Zhang C; Yang Q; Zhou G; Guo H; Chi J
Biomed Pharmacother; 2020 Oct; 130():110534. PubMed ID: 32711244
[TBL] [Abstract][Full Text] [Related]
37. Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression.
Lu Y; Liu W; Lv T; Wang Y; Liu T; Chen Y; Jin Y; Huang J; Zheng L; Huang Y; He Y; Li Y
Pharm Biol; 2022 Dec; 60(1):1616-1624. PubMed ID: 35980105
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats.
Behnia K; Boroujerdi M
J Pharm Pharmacol; 1999 Nov; 51(11):1275-82. PubMed ID: 10632085
[TBL] [Abstract][Full Text] [Related]
39. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
40. Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity.
Polat B; Suleyman H; Sener E; Akcay F
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):221-9. PubMed ID: 25316705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
